ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act By Ogkologos - June 11, 2025 762 0 Facebook Twitter Google+ Pinterest WhatsApp Ensuring equitable access to cancer treatments remains central to EU health security efforts Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor HSCT for Adult Patients with Haematologic Malignancies Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism MOST POPULAR Por qué el registro de médula ósea necesita más donantes diversos... February 8, 2022 Touching a nerve: How neuroscience could advance our understanding of cancer December 1, 2021 Are New Immune-Based Treatments for Kidney and Pancreatic Cancer on the... April 23, 2025 ‘A significant step forwards’ – treating patients with advanced biliary tract... March 30, 2021 Load more HOT NEWS Opinion: ‘Let’s not be short-sighted – the UK’s medical research charities... Breast Cancer Patient Is Accused of Having “Body Image Issues” After... 5 Tips to Move Beyond the Bedside Όροι χρήσης και προϋποθέσεις
